Dennis M. Abbott, D.D.S. is the founder and CEO of Dental Oncology Professionals (DOP), an oral medicine practice dedicated to care for the unique dental and oral health needs of individuals battling cancer. Inasmuch as the oral side effects of modern oncology therapies can cause intraoral sores, pain, and infections that can significantly reduce quality of life, DOP is committed to helping patients manage and overcome such obstacles so that cancer treatments can be continued according to schedule, proper nutrition maintained, and a high quality of life enjoyed before, during, and after cancer therapy.
Dr. Abbott holds a Bachelor of Arts in biology from Rice University in Houston, and is an honor graduate of Baylor College of Dentistry. After dental school, Dr. Abbott studied immunology, microbiology, and oral medicine at the School of Dental Medicine, State University of New York at Buffalo. In addition to private practice, he is a member of the dental oncology medical staff at Baylor Charles A. Sammons Cancer Center and Baylor University Medical Center in Dallas. Dr. Abbott also serves as a consultant to the national American Cancer Society in the development of oral monitoring guidelines for post-treatment cancer survivors.
Dr. Abbott has most recently conducted studies focusing on bisphosphonate-related osteonecrosis of the jaw and xerostomia in patients with cancer. He is the previous recipient of the Dentist Scientist Award and the National Research Service Award, both granted by the National Institutes of Health. Dr. Abbott is a guest author for many national dental publications on the subject of dental oncology and is a sought-after lecturer by various international companies on the topics of dental oncology, oral cancer, the role of oral health in systemic wellness, and antioxidants and oxidative stress in the oral health care of patients with cancer.